Dyadic International Inc (DYAI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $13.10M
Last updated: Nov 17, 2026 at 4:10 PM ET
Dyadic International Inc (DYAI) Statistics
Dyadic International (DYAI) has a market cap of $13.10M and an enterprise value of $14.27M. It kept -254.01% of revenue as net income over the last 12 months. Its share count is up 10.97% from a year earlier.
Total Valuation
Enterprise value is 8.95% above the market cap, as debt exceeds cash.
| Market Cap | $13.10M |
|---|---|
| Enterprise Value | $14.27M |
| Latest price (Nov 17, 2026) | $0.32 |
Key Dates
The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 4.4x. Its year-end P/S ranged from 11.9x to 170.9x from 2016 to 2025.
| P/S Ratio | 4.4x |
|---|---|
| Forward P/S | 2.0x |
Price Statistics
The stock is down 65.37% over 52 weeks and trades 21.95% below its 50-day average.
| Beta (1Y) | 1.02 |
|---|---|
| 52-Week Change | -65.37% |
| 1-Month Change | -17.04% |
| 3-Month Change | -57.23% |
| 6-Month Change | -56.17% |
| 5-Year Change | -91.44% |
| 10-Year Change | -76.67% |
| Total Return (1Y) | -65.37% |
| Total Return (3Y CAGR) | -43.03% |
| Total Return (5Y CAGR) | -38.68% |
| Max Drawdown (1Y) | -78.50% |
| Max Drawdown (3Y) | -86.08% |
| Sharpe Ratio (1Y) | -1.25 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $0.41 |
| 200-Day Average | $0.73 |
| 52-Week Range | $0.30 to $1.60 |
| RSI (14 Days) | 34.6 |
| Average Volume (20 Days) | 77.02K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.69x current liabilities.
| Current Ratio | 1.69x |
|---|---|
| Quick Ratio | 1.69x |
| Interest Coverage | -14.83x |
Returns and Efficiency
Return on invested capital is -205.53% over the last 12 months.
| Return on Assets (ROA) | -88.27% |
|---|---|
| Return on Invested Capital (ROIC) | -205.53% |
| Return on Capital Employed (ROCE) | -199.74% |
| ROA (5Y Average) | -69.52% |
| Asset Turnover | 0.28x |
| Receivables Turnover | 1.94x |
Scores
DYAI has an Altman Z-Score of -18.65, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -18.65 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $2.76M over the last 12 months is up 4.88% from the 12 months before.
| Revenue | $2.76M |
|---|---|
| Revenue Growth (YoY) | +4.88% |
| Gross Profit | $486.82K |
| Operating Income | -$7.30M |
| Pretax Income | -$7.00M |
| Net Income | -$7.00M |
| EBIT | -$6.56M |
| Reported EPS (TTM) | -$0.20 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $3.93M |
|---|---|
| Total Debt | $5.10M |
| Net Debt | $1.17M |
| Net Debt Per Share | $0.03 |
| Working Capital | $3.22M |
| Shareholder Equity | -$2.58M |
| Total Assets | $7.93M |
| Total Liabilities | $10.51M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $12 of capital spending, operating cash flow left -$7.04M of free cash flow.
| Operating Cash Flow | -$7.04M |
|---|---|
| Capital Expenditures | $12 |
| Free Cash Flow | -$7.04M |
| FCF Per Share | -$0.18 |
| Depreciation and Amortization | -$5.11K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -264.93%.
| Gross Margin | 17.66% |
|---|---|
| Operating Margin | -264.93% |
| Pretax Margin | -254.01% |
| Net Margin | -254.01% |
| EBIT Margin | -237.96% |
| FCF Margin | -255.20% |
| Gross Margin (5Y Average) | 11.21% |
Growth
Revenue fell 25.08% a year over 3 years.
| Revenue Growth (3Y CAGR) | -25.08% |
|---|---|
| Revenue Growth (5Y CAGR) | -5.11% |
| Book Value Per Share Growth (2Y CAGR) | -56.97% |
| Tangible Book Per Share Growth (2Y CAGR) | -56.97% |
Peer Position
Against 3 similar companies, DYAI has the 3rd highest P/S.
P/S RatioPeer median 5.3x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -4.60%
| P/S Ratio | 4.4x vs 5.3x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +4.88% vs -4.60% median |
Analyst Forecast
Consensus estimates put revenue growth at 222.80% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +222.80% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About DYAI
What is DYAI's market cap?
Dyadic International has a market cap of $13.10M. Its enterprise value, which adds debt and subtracts cash, is $14.27M.
How many shares of DYAI are outstanding?
Dyadic International has 38.29M shares outstanding. The count is up 10.97% from a year earlier.
Does DYAI pay a dividend?
No. Dyadic International does not pay a dividend.
How much debt does DYAI have?
Dyadic International has $5.10M of total debt and $3.93M of cash and equivalents, a net debt position of $1.17M.
DYAI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors